PA
PRME icon

Profund Advisors’s Prime Medicine PRME Stock Holding History

Profund Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Sell
72,624
-23,182
-24% -$77K 0.01% 881
2026
Q1 		$333K Buy
95,806
+26,201
+38% +$99.7K 0.01% 689
2025
Q4 		$242K Buy
+69,605
New +$310K 0.01% 1036
2023
Q4 		– Sell
-21,995
Closed -$210K – 1152
2023
Q3 		$210K Buy
+21,995
New +$286K 0.01% 868

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Profund Advisors's PRME Position: Q2 2026 in Review

Profund Advisors reduced its Prime Medicine (PRME) stake by 24% in Q2 2026, selling an estimated $77K and leaving 72,624 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #881.

Profund Advisors first reported a position in PRME in Q3 2023 and has held it in 4 quarters since. The position peaked at $333K in Q1 2026. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Profund Advisors held 72,624 shares of Prime Medicine worth $268K as of Q2 2026.
  • Profund Advisors sold 23,182 Prime Medicine shares in Q2 2026, an estimated $77K.
  • Prime Medicine made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #881 holding.
  • Profund Advisors first reported a position in Prime Medicine in Q3 2023 and has held it in 4 quarters since.
  • Profund Advisors's Prime Medicine position peaked at $333K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.